Mednet Logo
HomeNeurologyQuestion

When do you consider complement inhibitors or FcRN inhibitors in patients with myasthenia gravis?

2 Answers
Mednet Member
Mednet Member
Neurology · University of Minnesota

In my opinion, those meds should be considered for a patient with AchR antibody-positive MG who has suboptimal control of MG symptoms on:

  1. Pyridostigmine + prednisone + oral immunosuppressant drugs like azathioprine or MMF.
  2. Pyridostigmine + oral immunosuppressant + severe intolerance to steroids (si...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Neurology · Cedars-Sinai Medical Center

In theory, I agree with Dr. @Dr. First Last but for me, the answer is more complicated.

MMF and aza usually take many months to kick in, and it is not particularly useful to get the disease under control quickly. The concept that they should be used as "steroid-sparing agents" is good but one does a...

Register or Sign In to see full answer

When do you consider complement inhibitors or FcRN inhibitors in patients with myasthenia gravis? | Mednet